News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
Optimi Health
First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine
Compass Pathways
PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale
PsyBio Therapeutics
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
Pharmala Biotech Holdings
Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
Tryp Therapeutics
Cybin Announces the Development of a Scalable Psychedelic Facilitation Training Program, EMBARKCT
Cybin Inc.
Dr. Robin Carhart-Harris | Center for Psychedelic Research, Imperial College
Tryp Therapeutics
Mydecine Innovations Group
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
Compass Pathways
Prof. Matthew Johnson | Johns Hopkins University
No items found.
Christian Angermayer | Founder, atai Life Sciences
ATAI Life Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.